 | • レポートコード：MRC2102QY15836 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のワクチン用コンジュゲート市場について種類別（一価、多価、その他）、用途別（インフルエンザ、髄膜炎菌、肺炎球菌、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ワクチン用コンジュゲート市場の概要 ・世界の主要地域別ワクチン用コンジュゲート市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のワクチン用コンジュゲート市場規模2015-2026：種類別（一価、多価、その他） ・世界のワクチン用コンジュゲート市場規模2015-2026：用途別（インフルエンザ、髄膜炎菌、肺炎球菌、その他） ・ワクチン用コンジュゲートの米国市場規模2015-2020 ・ワクチン用コンジュゲートのヨーロッパ市場規模2015-2020 ・ワクチン用コンジュゲートの中国市場規模2015-2020 ・ワクチン用コンジュゲートの日本市場規模2015-2020 ・ワクチン用コンジュゲートの東南アジア市場規模2015-2020 ・ワクチン用コンジュゲートのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ワクチン用コンジュゲートの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ワクチン用コンジュゲートの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Vaccine Conjugate Market
The global Vaccine Conjugate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Vaccine Conjugate Scope and Market Size
The global Vaccine Conjugate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vaccine Conjugate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Vaccine Conjugate market is segmented into
Monovalent
Multivalent
Others
Segment by Application, the Vaccine Conjugate market is segmented into
Influenza
Meningococcal
Pneumococcal
Others
The Vaccine Conjugate market is analysed and market size information is provided by regions (countries). Segment by Application, the Vaccine Conjugate market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Vaccine Conjugate Market Share Analysis
Vaccine Conjugate market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Vaccine Conjugate business, the date to enter into the Vaccine Conjugate market, Vaccine Conjugate product introduction, recent developments, etc.
The major vendors covered:
Merck & Co.
GlaxoSmithKline plc.
SutroVax
Fablife.
Pfizer
Sinovac Biotech Ltd.
Sanofi Pasteur SA.
1 Vaccine Conjugate Market Overview
1.1 Vaccine Conjugate Product Scope
1.2 Vaccine Conjugate Segment by Type
1.2.1 Global Vaccine Conjugate Sales by Type (2020-2026)
1.2.2 Monovalent
1.2.3 Multivalent
1.2.4 Others
1.3 Vaccine Conjugate Segment by Application
1.3.1 Global Vaccine Conjugate Sales Comparison by Application (2020-2026)
1.3.2 Influenza
1.3.3 Meningococcal
1.3.4 Pneumococcal
1.3.5 Others
1.4 Vaccine Conjugate Market Estimates and Forecasts (2015-2026)
1.4.1 Global Vaccine Conjugate Sales Growth Rate (2015-2026)
1.4.2 Global Vaccine Conjugate Revenue and Growth Rate (2015-2026)
1.4.3 Global Vaccine Conjugate Price Trends (2015-2026)
2 Vaccine Conjugate Estimate and Forecast by Region
2.1 Global Vaccine Conjugate Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Vaccine Conjugate Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Vaccine Conjugate Sales Market Share by Region (2015-2020)
2.2.2 Global Vaccine Conjugate Revenue Market Share by Region (2015-2020)
2.3 Global Vaccine Conjugate Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Vaccine Conjugate Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Vaccine Conjugate Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Vaccine Conjugate Estimates and Projections (2015-2026)
2.4.2 Europe Vaccine Conjugate Estimates and Projections (2015-2026)
2.4.3 China Vaccine Conjugate Estimates and Projections (2015-2026)
2.4.4 Japan Vaccine Conjugate Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Vaccine Conjugate Estimates and Projections (2015-2026)
2.4.6 India Vaccine Conjugate Estimates and Projections (2015-2026)
3 Global Vaccine Conjugate Competition Landscape by Players
3.1 Global Top Vaccine Conjugate Players by Sales (2015-2020)
3.2 Global Top Vaccine Conjugate Players by Revenue (2015-2020)
3.3 Global Vaccine Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine Conjugate as of 2019)
3.4 Global Vaccine Conjugate Average Price by Company (2015-2020)
3.5 Manufacturers Vaccine Conjugate Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Vaccine Conjugate Players (Opinion Leaders)
4 Global Vaccine Conjugate Market Size by Type
4.1 Global Vaccine Conjugate Historic Market Review by Type (2015-2020)
4.1.1 Global Vaccine Conjugate Sales Market Share by Type (2015-2020)
4.1.2 Global Vaccine Conjugate Revenue Market Share by Type (2015-2020)
4.1.3 Global Vaccine Conjugate Price by Type (2015-2020)
4.2 Global Vaccine Conjugate Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Vaccine Conjugate Sales Forecast by Type (2021-2026)
4.2.2 Global Vaccine Conjugate Revenue Forecast by Type (2021-2026)
4.2.3 Global Vaccine Conjugate Price Forecast by Type (2021-2026)
5 Global Vaccine Conjugate Market Size by Application
5.1 Global Vaccine Conjugate Historic Market Review by Application (2015-2020)
5.1.1 Global Vaccine Conjugate Sales Market Share by Application (2015-2020)
5.1.2 Global Vaccine Conjugate Revenue Market Share by Application (2015-2020)
5.1.3 Global Vaccine Conjugate Price by Application (2015-2020)
5.2 Global Vaccine Conjugate Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Vaccine Conjugate Sales Forecast by Application (2021-2026)
5.2.2 Global Vaccine Conjugate Revenue Forecast by Application (2021-2026)
5.2.3 Global Vaccine Conjugate Price Forecast by Application (2021-2026)
6 United States Vaccine Conjugate Market Facts & Figures
6.1 United States Vaccine Conjugate Sales Market Share by Company (2015-2020)
6.2 United States Vaccine Conjugate Sales Market Share by Type (2015-2020)
6.3 United States Vaccine Conjugate Sales Market Share by Application (2015-2020)
7 Europe Vaccine Conjugate Market Facts & Figures
7.1 Europe Vaccine Conjugate Sales Market Share by Company (2015-2020)
7.2 Europe Vaccine Conjugate Sales Market Share by Type (2015-2020)
7.3 Europe Vaccine Conjugate Sales Market Share by Application (2015-2020)
8 China Vaccine Conjugate Market Facts & Figures
8.1 China Vaccine Conjugate Sales Market Share by Company (2015-2020)
8.2 China Vaccine Conjugate Sales Market Share by Type (2015-2020)
8.3 China Vaccine Conjugate Sales Market Share by Application (2015-2020)
9 Japan Vaccine Conjugate Market Facts & Figures
9.1 Japan Vaccine Conjugate Sales Market Share by Company (3015-3030)
9.2 Japan Vaccine Conjugate Sales Market Share by Type (2015-2020)
9.3 Japan Vaccine Conjugate Sales Market Share by Application (2015-2020)
10 Southeast Asia Vaccine Conjugate Market Facts & Figures
10.1 Southeast Asia Vaccine Conjugate Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Vaccine Conjugate Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Vaccine Conjugate Sales Market Share by Application (2015-2020)
11 India Vaccine Conjugate Market Facts & Figures
11.1 India Vaccine Conjugate Sales Market Share by Company (2015-2020)
11.2 India Vaccine Conjugate Sales Market Share by Type (2015-2020)
11.3 India Vaccine Conjugate Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Vaccine Conjugate Business
12.1 Merck & Co.
12.1.1 Merck & Co. Corporation Information
12.1.2 Merck & Co. Business Overview
12.1.3 Merck & Co. Vaccine Conjugate Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck & Co. Vaccine Conjugate Products Offered
12.1.5 Merck & Co. Recent Development
12.2 GlaxoSmithKline plc.
12.2.1 GlaxoSmithKline plc. Corporation Information
12.2.2 GlaxoSmithKline plc. Business Overview
12.2.3 GlaxoSmithKline plc. Vaccine Conjugate Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GlaxoSmithKline plc. Vaccine Conjugate Products Offered
12.2.5 GlaxoSmithKline plc. Recent Development
12.3 SutroVax
12.3.1 SutroVax Corporation Information
12.3.2 SutroVax Business Overview
12.3.3 SutroVax Vaccine Conjugate Sales, Revenue and Gross Margin (2015-2020)
12.3.4 SutroVax Vaccine Conjugate Products Offered
12.3.5 SutroVax Recent Development
12.4 Fablife.
12.4.1 Fablife. Corporation Information
12.4.2 Fablife. Business Overview
12.4.3 Fablife. Vaccine Conjugate Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Fablife. Vaccine Conjugate Products Offered
12.4.5 Fablife. Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Vaccine Conjugate Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Vaccine Conjugate Products Offered
12.5.5 Pfizer Recent Development
12.6 Sinovac Biotech Ltd.
12.6.1 Sinovac Biotech Ltd. Corporation Information
12.6.2 Sinovac Biotech Ltd. Business Overview
12.6.3 Sinovac Biotech Ltd. Vaccine Conjugate Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sinovac Biotech Ltd. Vaccine Conjugate Products Offered
12.6.5 Sinovac Biotech Ltd. Recent Development
12.7 Sanofi Pasteur SA.
12.7.1 Sanofi Pasteur SA. Corporation Information
12.7.2 Sanofi Pasteur SA. Business Overview
12.7.3 Sanofi Pasteur SA. Vaccine Conjugate Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sanofi Pasteur SA. Vaccine Conjugate Products Offered
12.7.5 Sanofi Pasteur SA. Recent Development
…
13 Vaccine Conjugate Manufacturing Cost Analysis
13.1 Vaccine Conjugate Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Vaccine Conjugate
13.4 Vaccine Conjugate Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Vaccine Conjugate Distributors List
14.3 Vaccine Conjugate Customers
15 Market Dynamics
15.1 Vaccine Conjugate Market Trends
15.2 Vaccine Conjugate Opportunities and Drivers
15.3 Vaccine Conjugate Market Challenges
15.4 Vaccine Conjugate Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Vaccine Conjugate Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Vaccine Conjugate Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Vaccine Conjugate Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Vaccine Conjugate Sales (K MT) by Region (2015-2020)
Table 5. Global Vaccine Conjugate Sales Market Share by Region (2015-2020)
Table 6. Global Vaccine Conjugate Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Vaccine Conjugate Revenue Share by Region (2015-2020)
Table 8. Global Vaccine Conjugate Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Vaccine Conjugate Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Vaccine Conjugate Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Vaccine Conjugate Revenue Share Forecast by Region (2021-2026)
Table 12. Global Vaccine Conjugate (K MT) of Key Companies (2015-2020)
Table 13. Global Vaccine Conjugate Sales Share by Company (2015-2020)
Table 14. Global Vaccine Conjugate Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Vaccine Conjugate Revenue Share by Company (2015-2020)
Table 16. Global Vaccine Conjugate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine Conjugate as of 2019)
Table 17. Global Vaccine Conjugate Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Vaccine Conjugate Manufacturing Sites and Area Served
Table 19. Manufacturers Vaccine Conjugate Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Vaccine Conjugate Players
Table 22. Global Vaccine Conjugate Sales (K MT) by Type (2015-2020)
Table 23. Global Vaccine Conjugate Sales Share by Type (2015-2020)
Table 24. Global Vaccine Conjugate Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Vaccine Conjugate Price (K MT) by Type (2015-2020)
Table 26. Global Vaccine Conjugate Sales Share by Type (2021-2026)
Table 27. Global Vaccine Conjugate Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Vaccine Conjugate Revenue Share by Type (2021-2026)
Table 29. Global Vaccine Conjugate Price (K MT) by Type (2021-2026)
Table 30. Global Vaccine Conjugate Sales (K MT) by Application (2015-2020)
Table 31. Global Vaccine Conjugate Sales Share by Application (2015-2020)
Table 32. Global Vaccine Conjugate Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Vaccine Conjugate Price (K MT) by Application (2015-2020)
Table 34. Global Vaccine Conjugate Sales (K MT) by Application (2021-2026)
Table 35. Global Vaccine Conjugate Sales Share by Application (2021-2026)
Table 36. Global Vaccine Conjugate Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Vaccine Conjugate Revenue Share by Application (2021-2026)
Table 38. Global Vaccine Conjugate Price (K MT) by Application (2021-2026)
Table 39. United States Vaccine Conjugate Sales (K MT) by Company (2015-2020)
Table 40. United States Vaccine Conjugate Sales Market Share by Company (2015-2020)
Table 41. United States Vaccine Conjugate Sales (K MT) by Type (2015-2020)
Table 42. United States Vaccine Conjugate Sales Market Share by Type (2015-2020)
Table 43. United States Vaccine Conjugate Sales (K MT) by Application (2015-2020)
Table 44. United States Vaccine Conjugate Sales Market Share by Application (2015-2020)
Table 45. Europe Vaccine Conjugate Sales (K MT) by Company (2015-2020)
Table 46. Europe Vaccine Conjugate Sales Market Share by Company (2015-2020)
Table 47. Europe Vaccine Conjugate Sales (K MT) by Type (2015-2020)
Table 48. Europe Vaccine Conjugate Sales Market Share by Type (2015-2020)
Table 49. Europe Vaccine Conjugate Sales (K MT) by Application (2015-2020)
Table 50. Europe Vaccine Conjugate Sales Market Share by Type (2015-2020)
Table 51. China Vaccine Conjugate Sales (K MT) by Company (2015-2020)
Table 52. China Vaccine Conjugate Sales Market Share by Company (2015-2020)
Table 53. China Vaccine Conjugate Sales (K MT) by Type (2015-2020)
Table 54. China Vaccine Conjugate Sales Market Share by Type (2015-2020)
Table 55. China Vaccine Conjugate Sales (K MT) by Application (2015-2020)
Table 56. China Vaccine Conjugate Sales Market Share by Application (2015-2020)
Table 57. Japan Vaccine Conjugate Sales (K MT) by Company (2015-2020)
Table 58. Japan Vaccine Conjugate Sales Market Share by Company (2015-2020)
Table 59. Japan Vaccine Conjugate Sales (K MT) by Type (2015-2020)
Table 60. Japan Vaccine Conjugate Sales Market Share by Type (2015-2020)
Table 61. Japan Vaccine Conjugate Sales (K MT) by Application (2015-2020)
Table 62. Japan Vaccine Conjugate Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Vaccine Conjugate Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Vaccine Conjugate Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Vaccine Conjugate Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Vaccine Conjugate Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Vaccine Conjugate Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Vaccine Conjugate Sales Market Share by Application (2015-2020)
Table 69. India Vaccine Conjugate Sales (K MT) by Company (2015-2020)
Table 70. India Vaccine Conjugate Sales Market Share by Company (2015-2020)
Table 71. India Vaccine Conjugate Sales (K MT) by Type (2015-2020)
Table 72. India Vaccine Conjugate Sales Market Share by Type (2015-2020)
Table 73. India Vaccine Conjugate Sales (K MT) by Application (2015-2020)
Table 74. India Vaccine Conjugate Sales Market Share by Application (2015-2020)
Table 75. Merck & Co. Corporation Information
Table 76. Merck & Co. Description and Business Overview
Table 77. Merck & Co. Vaccine Conjugate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Merck & Co. Vaccine Conjugate Product
Table 79. Merck & Co. Recent Development
Table 80. GlaxoSmithKline plc. Corporation Information
Table 81. GlaxoSmithKline plc. Description and Business Overview
Table 82. GlaxoSmithKline plc. Vaccine Conjugate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. GlaxoSmithKline plc. Vaccine Conjugate Product
Table 84. GlaxoSmithKline plc. Recent Development
Table 85. SutroVax Corporation Information
Table 86. SutroVax Description and Business Overview
Table 87. SutroVax Vaccine Conjugate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. SutroVax Vaccine Conjugate Product
Table 89. SutroVax Recent Development
Table 90. Fablife. Corporation Information
Table 91. Fablife. Description and Business Overview
Table 92. Fablife. Vaccine Conjugate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Fablife. Vaccine Conjugate Product
Table 94. Fablife. Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Vaccine Conjugate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Pfizer Vaccine Conjugate Product
Table 99. Pfizer Recent Development
Table 100. Sinovac Biotech Ltd. Corporation Information
Table 101. Sinovac Biotech Ltd. Description and Business Overview
Table 102. Sinovac Biotech Ltd. Vaccine Conjugate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Sinovac Biotech Ltd. Vaccine Conjugate Product
Table 104. Sinovac Biotech Ltd. Recent Development
Table 105. Sanofi Pasteur SA. Corporation Information
Table 106. Sanofi Pasteur SA. Description and Business Overview
Table 107. Sanofi Pasteur SA. Vaccine Conjugate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Sanofi Pasteur SA. Vaccine Conjugate Product
Table 109. Sanofi Pasteur SA. Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Vaccine Conjugate Distributors List
Table 113. Vaccine Conjugate Customers List
Table 114. Vaccine Conjugate Market Key Trends
Table 115. Vaccine Conjugate Key Opportunities and Drivers
Table 116. Vaccine Conjugate Market Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccine Conjugate Product Picture
Figure 2. Global Vaccine Conjugate Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Vaccine Conjugate Market Share by Application in 2020 & 2026
Figure 6. Influenza Examples
Figure 7. Meningococcal Examples
Figure 8. Pneumococcal Examples
Figure 9. Others Examples
Figure 10. Global Vaccine Conjugate Sales (K MT) Growth Rate (2015-2026)
Figure 11. Global Vaccine Conjugate Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Vaccine Conjugate Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Vaccine Conjugate Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Vaccine Conjugate Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Vaccine Conjugate Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Vaccine Conjugate Sales (K MT) Growth Rate (2015-2026)
Figure 17. Europe Vaccine Conjugate Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Vaccine Conjugate Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Vaccine Conjugate Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Vaccine Conjugate Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Vaccine Conjugate Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Vaccine Conjugate Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Vaccine Conjugate Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Vaccine Conjugate Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Vaccine Conjugate Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Vaccine Conjugate Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Vaccine Conjugate Players Market Share by Revenue in Vaccine Conjugate 2015 & 2019
Figure 28. Vaccine Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Vaccine Conjugate Revenue Share by Type (2015-2020)
Figure 30. Global Vaccine Conjugate Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Vaccine Conjugate Revenue Share by Application (2015-2020)
Figure 32. Global Vaccine Conjugate Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Vaccine Conjugate Sales Market Share by Type in 2019
Figure 34. United States Vaccine Conjugate Sales Market Share by Type in 2019
Figure 35. Europe Vaccine Conjugate Sales Market Share by Company in 2019
Figure 36. Europe Vaccine Conjugate Sales Market Share by Type in 2019
Figure 37. Europe Vaccine Conjugate Sales Market Share by Application in 2019
Figure 38. China Vaccine Conjugate Sales Market Share by Company in 2019
Figure 39. China Vaccine Conjugate Sales Market Share by Type in 2019
Figure 40. China Vaccine Conjugate Sales Market Share by Application in 2019
Figure 41. Japan Vaccine Conjugate Sales Market Share by Company in 2019
Figure 42. Japan Vaccine Conjugate Sales Market Share by Type in 2019
Figure 43. Japan Vaccine Conjugate Sales Market Share by Application in 2019
Figure 44. Southeast Asia Vaccine Conjugate Sales Market Share by Company in 2019
Figure 45. Southeast Asia Vaccine Conjugate Sales Market Share by Type in 2019
Figure 46. Southeast Asia Vaccine Conjugate Sales Market Share by Application in 2019
Figure 47. India Vaccine Conjugate Sales Market Share by Company in 2019
Figure 48. India Vaccine Conjugate Sales Market Share by Type in 2019
Figure 49. India Vaccine Conjugate Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Vaccine Conjugate
Figure 52. Manufacturing Process Analysis of Vaccine Conjugate
Figure 53. Vaccine Conjugate Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
23価肺炎球菌多糖体ワクチンの世界市場レポート2020 23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in …- インフルエンザワクチンの世界市場レポート2020 Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…
- 麻疹（はしか）ワクチンの世界市場レポート2020 Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles. Market Analysis and Insights: Global Measl…
- 点鼻ワクチンの世界市場レポート2020 Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza. The FluMist is the only alternative to the flu shot without a needle and is given in the form of a nasal spray. Nasal Spray Vaccine is widely sales for Child and Adult The most proportion of Nasal …
- 弱毒生水痘ワクチンの世界市場レポート2020 A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella. The downstream industries of varicella attenuated live vaccine products are kids and adults. In the recent years, with the recovery of global economic, the development of em…